MBio lands $5.2 million federal grant

BOULDER – MBio Diagnostics Inc. has received a $5.2 million grant from the National Institutes of Health to continue work on its flu test.

The five-year grant will be doled out in portions of about $1 million per year, said Michael Lochhead, vice president of the Boulder-based company. The company will use the money to figure out how to quickly reconfigure flu tests to respond to new or emerging infectious agents, Lochhead said in a statement.

“It’s a big one for us. It’s exciting,” Lochhead said of the grant, which came from NIH’s Partnerships for Biodefense program.

The new test may be more…